Peter Stockham
Overview
Explore the profile of Peter Stockham including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Isoardi K, Alfred S, Weber C, Harris K, Soderstrom J, Syrjanen R, et al.
Drug Alcohol Rev
. 2025 Jan;
PMID: 39828943
Introduction: Nitazenes are a group of potent synthetic opioids that have had increasing prominence as novel psychoactive drugs in the last 5 years. We describe emergency department nitazene-related presentations. Methods:...
2.
Partridge E, Stockham P, Kenneally M, Luong A, Kostakis C, Alfred S
Emerg Med Australas
. 2024 Oct;
37(1):e14512.
PMID: 39389919
Objective: To highlight the detection of xylazine and nitrazolam in conjunction with benzimidazole opioids (nitazenes) and other novel benzodiazepines in a cluster of patients after putative heroin use. Methods: Deidentified...
3.
Trobbiani S, Stockham P, Kostakis C
J Anal Toxicol
. 2023 Aug;
47(9):807-817.
PMID: 37632762
A sensitive method for the qualitative screening of synthetic cannabinoids and opioids in whole blood was developed and validated using alkaline liquid-liquid extraction (LLE) and liquid chromatography-time-of-flight mass spectrometry (LC-QTOF-MS)....
4.
Stockham P, Partridge E, Alfred S, Boyle L, Camilleri A, Green H, et al.
Clin Toxicol (Phila)
. 2023 May;
61(4):241-247.
PMID: 37129222
Background: Gamma-hydroxybutyrate is a potent central nervous system depressant with a narrow recreational dose window and analytical detection time. We describe data relating to intoxicated patients presenting to emergency departments...
5.
Alfred S, Stockham P, Partridge E, Ward A, Green H, Mallon J, et al.
Med J Aust
. 2023 Mar;
218(8):376-377.
PMID: 36977652
No abstract available.
6.
Stephenson L, Kenneally M, Van Den Heuvel C, Humphries M, Stockham P, Byard R
Leg Med (Tokyo)
. 2021 Jun;
53:101928.
PMID: 34119997
A study was undertaken of 51 cases where barbiturates were detected in post-mortem blood samples from 2000 to 2019 at Forensic Science South Australia, Adelaide, Australia. The cause of death...
7.
Camilleri A, Alfred S, Gerber C, Lymb S, Painter B, Rathjen A, et al.
Forensic Sci Med Pathol
. 2021 May;
17(3):388-394.
PMID: 34013465
Australia does not have a formal drug early warning system. A coordinated program of fixed or event-based drug-checking is expensive and provides harm reduction information to atargeted user group. The...
8.
Partridge E, Alfred S, Camilleri A, Green H, Haustead D, Kostakis C, et al.
Emerg Med Australas
. 2021 Mar;
33(5):883-887.
PMID: 33713558
Objective: ED presentations because of illicit use of psychotropic drugs and pharmaceuticals result in significant medical harm and resource consumption. Patient assessment is complicated by the regular emergence of new...
9.
Stephenson L, Stockham P, Van Den Heuvel C, Byard R
Leg Med (Tokyo)
. 2020 Sep;
47:101783.
PMID: 32919339
A study was undertaken of all drowning deaths that occurred over a 30-year period from 1988 to 2017 in the urban section of the River Torrens, Adelaide, South Australia, an...
10.
Bade R, Abbate V, Abdelaziz A, Nguyen L, Trobbiani S, Stockham P, et al.
Drug Test Anal
. 2020 Jul;
12(10):1494-1500.
PMID: 32621345
Consumption of new psychoactive substances (NPS) is an international problem for health, policing, forensic, and analytical laboratories. The transience of these substances in the community, combined with continual slight structural...